India, Oct. 22 -- A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said.

Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial.

According to Brazilian newspaper O Globo, the volunteer was part of the control group and had been given a placebo and not the trial Covid vaccine. The clinical trial would have been suspended if the volunteer had received the COVID-19 vaccine.

The volunteer was a 28-year-old man, who died from COVID-19 complications.

Brazil's Federal University of Sao Paulo, which is helping t...